Stratton SP et al. |
A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer. |
2010 |
Cancer Prev Res (Phila) |
pmid:20103724
|
Clifford JL and DiGiovanni J |
The promise of natural products for blocking early events in skin carcinogenesis. |
2010 |
Cancer Prev Res (Phila) |
pmid:20103730
|
Chaudhary SC et al. |
Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. |
2009 |
Chem. Biol. Interact. |
pmid:19161993
|
Da Fonseca CO et al. |
Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol. |
2009 |
Invest New Drugs |
pmid:19139816
|
Magkouta S et al. |
Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis lung carcinoma. |
2009 |
Nutr Cancer |
pmid:19838938
|
Zhou W et al. |
Components of lemon essential oil attenuate dementia induced by scopolamine. |
2009 |
Nutr Neurosci |
pmid:19356307
|
Kim D and Ortiz de Montellano PR |
Tricistronic overexpression of cytochrome P450cam, putidaredoxin, and putidaredoxin reductase provides a useful cell-based catalytic system. |
2009 |
Biotechnol. Lett. |
pmid:19458919
|
da Fonseca CO et al. |
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol. |
2008 Jul-Aug |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:18726148
|
Bailey HH et al. |
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. |
2008 |
Cancer Chemother. Pharmacol. |
pmid:17885756
|
da Fonseca CO et al. |
Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. |
2008 |
Surg Neurol |
pmid:18295834
|